搜索临床试验以:Lapatinib /- Trastuzumab and MM-111
总计5269个结果
-
Merrimack Pharmaceuticals终止
-
Merrimack Pharmaceuticals完全的
-
AO Clinical Investigation and Publishing Documentation完全的
-
Merrimack Pharmaceuticals完全的
-
Elevation Oncology终止
-
Aldagen终止
-
Ankyra Therapeutics, Inc招聘中
-
Aardvark Therapeutics, Inc.Children's Hospital Colorado; Stanford University招聘中
-
Elevation OncologyMerrimack Pharmaceuticals终止
-
Merrimack PharmaceuticalsSanofi完全的
-
Merrimack PharmaceuticalsSanofi完全的
-
Fondation Hôpital Saint-Joseph尚未招聘
-
Aardvark Therapeutics, Inc.University of California, San Diego完全的
-
Merrimack PharmaceuticalsSanofi完全的
-
European Organisation for Research and Treatment...GlaxoSmithKline完全的
-
Pamela Munster撤销晚期实体瘤 | 脑转移 | 记录在案的 Her2 过度表达 | 神经稳定
-
Azienda Ospedaliera Ordine Mauriziano di Torino未知
-
Merrimack PharmaceuticalsSanofi完全的
-
Jonsson Comprehensive Cancer CenterGlaxoSmithKline完全的
-
Merrimack Pharmaceuticals终止
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Berufsverband Niedergelassener Gynäkologischer...OnkoDataMed GmbH撤销
-
Novartis Pharmaceuticals完全的转移,脑西班牙, 匈牙利, 波兰, 德国, 意大利, 俄罗斯联邦, 瑞典, 英国, 泰国, 美国, 比利时, 法国, 希腊, 丹麦
-
Cancer Trials Ireland完全的
-
Institute of Cancer Research, United KingdomNovartis; Cancer Research UK; Manchester University NHS Foundation Trust; University of Manchester主动,不招人
-
Merrimack Pharmaceuticals完全的
-
Fondazione del Piemonte per l'Oncologia未知
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Translational Oncology Research InternationalNational Cancer Institute (NCI); University of California, Los Angeles完全的
-
Byondis B.V.完全的